Literature DB >> 2026225

Seroepidemiology of pertussis infection in an urban childhood population in Cameroon.

T Stroffolini1, A Giammanco, A Chiarini, S Taormina, A Sarzana, G Mazza, M Maggio, M Chiaramonte, T Ngatchu, D Lantum.   

Abstract

In 1989, the prevalence of IgG antibodies to pertussis toxin (PT) in a sample of 367 unvaccinated apparently healthy children 5-14 years old was estimated by ELISA in Kumba City (Cameroon). Children were recruited using a systematic random sampling from six primary schools located in different districts of the city. The sample was representative of the various socioeconomic classes. The overall prevalence was 75%; it increased from 62% in 5 year old children to 81% in children 12-14 years old (P less than 0.01). IgG antibody prevalence was positively related to the family size. Children belonging to households of nine or more members had a 2.2-fold risk (C.I. 95 per cent = 1.1-4.6) of previous exposure to B. pertussis infection. No association was found with the father's occupation (O.R. = 1). These findings demonstrate a great impact of pertussis infection in Cameroon, with a nearly total exposure by late childhood.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026225     DOI: 10.1007/bf00221343

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Prevalence of pertussis IgG antibodies in children in Palermo, Italy.

Authors:  T Stroffolini; A Giammanco; L De Crescenzo; F Lupo; V Nicosia; G Torres; A R Valenza; A Cascio; S Taormina; L Nisticò
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

2.  Pertussis: epidemiology and control.

Authors:  A S Muller; J Leeuwenburg; D S Pratt
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

3.  Whooping cough in Uganda.

Authors:  N O Bwibo
Journal:  Scand J Infect Dis       Date:  1971

4.  Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.

Authors:  G Zackrisson; I Krantz; T Lagergård; P Larsson; R Sekura; N Sigurs; J Taranger; B Trollfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

5.  Serum IgA antibody to Bordetella pertussis as an indicator of infection.

Authors:  J Nagel; E J Poot-Scholtens
Journal:  J Med Microbiol       Date:  1983-11       Impact factor: 2.472

6.  Detection of antibodies in human serum against the fimbrial haemagglutinin of Bordetella pertussis by enzyme-linked immunosorbent assay.

Authors:  M Granström; A A Lindberg; P Askelöf; B Hederstedt
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

7.  Serological diagnosis of pertussis: IgM, IgA and IgG antibodies against Bordetella pertussis measured by enzyme-linked immunosorbent assay (ELISA).

Authors:  M K Viljanen; O Ruuskanen; C Granberg; T T Salmi
Journal:  Scand J Infect Dis       Date:  1982

Review 8.  The concept of pertussis as a toxin-mediated disease.

Authors:  M Pittman
Journal:  Pediatr Infect Dis       Date:  1984 Sep-Oct

9.  Pertussis in a rural area of Kenya: epidemiology and results of a vaccine trial.

Authors:  A S Muller; J Leeuwenburg; A M Voorhoeve
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

10.  Dissecting human T cell responses against Bordetella species.

Authors:  M T De Magistris; M Romano; S Nuti; R Rappuoli; A Tagliabue
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  2 in total

1.  Rapid immunodot technique for identifying Bordetella pertussis.

Authors:  G N Sanden; P K Cassiday; J M Barbaree
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

Review 2.  Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Africa.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-04-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.